Course summary

Learn how to develop treatments for some of the world’s most challenging diseases of our time. You will develop key aspects of the drug discovery journey, from initial concept through to clinical treatment. This course is accredited by the Royal Society of Chemistry. Research Together with colleagues from the Faculty of Medicine and Health Sciences, we are joint 1st in the UK on Research Environment in the Research Excellence Framework 2021. Research from the School of Pharmacy is transforming the lives of millions of people across the globe. Some of our recent contributions include:

• developing an innovative materials discovery platform, leading to improved biomedical devices that reduce infection and improve healing

• helping the NHS save £500m through research into the expansion of pharmacy services in England

• influencing government policy internationally to establish community pharmacies as vaccination centres for influenza and COVID-19

• Computational chemistry - Identification of Potential Inhibitors against Factor XII related to COVID-19 using Molecular Docking

• Synthetic organic/medicinal chemistry - Facile synthetic approaches to CGP-12177 analogues for exploring the β1-adrenoceptor secondary conformation

• In silico pharmacokinetics - Evaluation of the impact of CYP2C8 polymorphisms on the efficacy and disposition of amodiaquine using physiologically based pharmacokinetic modelling

• Drug screening - Characterization of RO7297590 binding properties to human cannabinoid CB1 and CB2 receptors using homogenous time-resolved fluorescence (HTRF)

• Target identification - Targeting protease inhibitors to the gut-associated lymphoid tissues for improved treatment of HIV/AIDS